NEPHROPLUS Q1 FY27 results at a glance
NEPHROCARE HEALTH SERV L Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹282 cr |
|---|
| Revenue YoY | +23.7% |
|---|
| Operating profit | ₹39.34 cr |
|---|
| Operating margin | 14.0% |
|---|
| Net profit | ₹31.97 cr |
|---|
| Net profit YoY | +34.9% |
|---|
| Net profit QoQ | +5.3% |
|---|
| Net margin | 11.3% |
|---|
| Basic EPS | ₹3.19 |
|---|
| TTM revenue | ₹1,051 cr |
|---|
| TTM net profit | ₹85.11 cr |
|---|
| TTM net margin | 8.1% |
|---|
NEPHROPLUS Q1 FY27 results: what the numbers say
NEPHROCARE HEALTH SERV L (NEPHROPLUS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹282 cr and a net profit of ₹31.97 cr, translating into earnings per share of ₹3.19.
Compared with the same quarter a year earlier, revenue grew strongly by +23.7% and net profit grew strongly by +34.9%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹39.34 cr, an operating margin of 14.0% versus 12.3% a year ago — a gain of 1.7 percentage points.
NEPHROPLUS quarter-wise results table
Net profit
₹31.97 cr
+34.9% YoY
Operating profit
₹39.34 cr
+40.3% YoY
NEPHROCARE HEALTH SERV L (NEPHROPLUS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹282 cr | ₹39.34 cr | ₹31.97 cr | 14.0% | 11.3% | ₹3.19 | +34.9% | +5.3% |
| Q4 FY262026-03-31 | ₹266 cr | ₹27.92 cr | ₹30.37 cr | 10.5% | 11.4% | ₹3.03 | — | -5.8% |
| Q3 FY262025-12-31 | ₹260 cr | ₹39 cr | ₹32.24 cr | 15.0% | 12.4% | ₹3.43 | — | +440.2% |
| Q2 FY262025-09-30 | ₹244 cr | ₹41.89 cr | -₹9.48 cr | 17.2% | -3.9% | — | — | -140.0% |
| Q1 FY262025-06-30 | ₹228 cr | ₹28.05 cr | ₹23.7 cr | 12.3% | 10.4% | ₹2.36 | — | — |
| TTM (last 4 quarters) | ₹1,051 cr | ₹148 cr | ₹85.11 cr | 14.1% | 8.1% | — | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
NEPHROPLUS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
NEPHROCARE HEALTH SERV L quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹282 cr | ₹266 cr | ₹260 cr | ₹244 cr | ₹228 cr |
|---|
| Total expenses | ₹242 cr | ₹238 cr | ₹221 cr | ₹202 cr | ₹200 cr |
|---|
| Gross profit | ₹167 cr | ₹155 cr | ₹151 cr | ₹142 cr | ₹130 cr |
|---|
| Operating profit (EBIT) | ₹39.34 cr | ₹27.92 cr | ₹39 cr | ₹41.89 cr | ₹28.05 cr |
|---|
| Operating margin | 14.0% | 10.5% | 15.0% | 17.2% | 12.3% |
|---|
| Interest cost | ₹2.21 cr | ₹3.18 cr | ₹5.96 cr | ₹44.16 cr | ₹6.1 cr |
|---|
| Profit before tax | ₹41.03 cr | ₹33.22 cr | ₹36.36 cr | -₹0.63 cr | ₹28.52 cr |
|---|
| Tax expense | ₹9.06 cr | ₹2.85 cr | ₹4.12 cr | ₹8.85 cr | ₹4.82 cr |
|---|
| Effective tax rate | 22.1% | 8.6% | 11.3% | -1413.7% | 16.9% |
|---|
| Net profit (PAT) | ₹31.97 cr | ₹30.37 cr | ₹32.24 cr | -₹9.48 cr | ₹23.7 cr |
|---|
| Net profit margin | 11.3% | 11.4% | 12.4% | -3.9% | 10.4% |
|---|
| Basic EPS | ₹3.19 | ₹3.03 | ₹3.43 | — | ₹2.36 |
|---|
| Diluted EPS | ₹3.11 | ₹2.96 | ₹3.35 | — | ₹2.36 |
|---|
NEPHROPLUS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +23.7% | — | — | — | — |
|---|
| Revenue QoQ | +6.1% | +2.3% | +6.6% | +7.0% | — |
|---|
| Operating profit YoY | +40.3% | — | — | — | — |
|---|
| Operating profit QoQ | +40.9% | -28.4% | -6.9% | +49.4% | — |
|---|
| Net profit YoY | +34.9% | — | — | — | — |
|---|
| Net profit QoQ | +5.3% | -5.8% | +440.2% | -140.0% | — |
|---|
| EPS YoY | +35.0% | — | — | — | — |
|---|
| EPS QoQ | +5.3% | -11.7% | — | — | — |
|---|
NEPHROPLUS annual results history
Full-year performance for NEPHROCARE HEALTH SERV L, useful for reading each quarter in context.
NEPHROCARE HEALTH SERV L annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹994 cr | ₹748 cr | ₹540 cr | ₹415 cr |
|---|
| Total expenses | ₹856 cr | ₹649 cr | ₹486 cr | ₹411 cr |
|---|
| Gross profit | ₹576 cr | ₹396 cr | ₹256 cr | ₹193 cr |
|---|
| Operating profit (EBIT) | ₹139 cr | ₹98.98 cr | ₹53.47 cr | ₹3.64 cr |
|---|
| Operating margin | 14.0% | 13.2% | 9.9% | 0.9% |
|---|
| Interest cost | ₹57.97 cr | ₹18.87 cr | ₹19 cr | ₹14.59 cr |
|---|
| Profit before tax | ₹97.47 cr | ₹87.44 cr | ₹33.16 cr | -₹8.59 cr |
|---|
| Tax expense | ₹20.63 cr | ₹20.34 cr | -₹1.97 cr | ₹3.2 cr |
|---|
| Effective tax rate | 21.2% | 23.3% | -5.9% | -37.2% |
|---|
| Net profit (PAT) | ₹76.84 cr | ₹67.1 cr | ₹35.13 cr | -₹11.79 cr |
|---|
| Net profit margin | 7.7% | 9.0% | 6.5% | -2.8% |
|---|
| Basic EPS | ₹8.48 | ₹6.69 | ₹3.50 | ₹-1.17 |
|---|
| Diluted EPS | ₹8.10 | ₹6.69 | ₹3.50 | ₹-1.17 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹282 cr against ₹228 cr in Q1 FY26, and ₹266 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +6.1%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹242 cr, or 86.0% of revenue, with operating profit grew +40.3% year on year.
Margins, tax and profitability
Net profit of ₹31.97 cr works out to a net margin of 11.3% compared with 10.4% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, NEPHROCARE HEALTH SERV L reported profit before tax of ₹41.03 cr, a tax charge of ₹9.06 cr (effective rate 22.1%), interest cost of ₹2.21 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹30.37 cr in Q4 FY26 to ₹31.97 cr in Q1 FY27, a change of +5.3%.
Trailing twelve months and annual context
Across the trailing four quarters NEPHROCARE HEALTH SERV L has generated revenue of ₹1,051 cr and net profit of ₹85.11 cr, a trailing net margin of 8.1%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹994 cr with net profit of ₹76.84 cr and EPS of ₹8.48, versus the prior year where revenue grew +32.9% and profit grew +14.5%.
What to watch in the next NEPHROPLUS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
NEPHROCARE HEALTH SERV L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
NEPHROPLUS results coverage
No results report published for NEPHROPLUS yet — our desk covers each quarter within minutes of the filing.
More on NEPHROPLUS
NEPHROPLUS quarterly results FAQs
What were NEPHROCARE HEALTH SERV L (NEPHROPLUS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), NEPHROCARE HEALTH SERV L reported revenue of ₹282 cr and net profit of ₹31.97 cr, a change of +34.9% year on year on +23.7% revenue growth. EPS stood at ₹3.19.
What is NEPHROPLUS profit margin in Q1 FY27?
NEPHROCARE HEALTH SERV L posted a net profit margin of 11.3% and an operating margin of 14.0% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹1,051 cr and net profit ₹85.11 cr.
Did NEPHROPLUS results beat the previous quarter?
NEPHROCARE HEALTH SERV L net profit changed +5.3% quarter on quarter, from ₹30.37 cr in Q4 FY26 to ₹31.97 cr in Q1 FY27.
When are NEPHROCARE HEALTH SERV L (NEPHROPLUS) quarterly results?
NEPHROCARE HEALTH SERV L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see NEPHROPLUS latest quarterly results?
Results coverage for NEPHROPLUS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the NEPHROPLUS stock page.
What is NEPHROCARE HEALTH SERV L annual revenue and profit?
For FY26, NEPHROCARE HEALTH SERV L reported full-year revenue of ₹994 cr and net profit of ₹76.84 cr, with EPS of ₹8.48.
How many quarterly results has NEPHROPLUS declared recently?
Past results dates for NEPHROPLUS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 10 Sept 2026. For information only, not investment advice.
